Merck Announces 2016 Recipients of EUR1 Million Grant for Multiple Sclerosis Innovation
DARMSTADT, Germany, September 15, 2016/PRNewswire/ -- Merck, a leading science and technology company, today announced recipients of the fourth annual Grant for Multiple Sclerosis Innovation (GMSI) during a symposium at the 32nd Congress of the European Committee for Treatment and Research in Multiple Sclerosis (ECTRIMS) in London.
Читать дальше...